REFERENCES
- Benn P. Trisomy 16 and trisomy 16 Mosaicism: A review. Am J Med Genet 1998;79:121–133.
- Yong PJ, Langlois S, von Dadelszen P, Robinson W. The association between preeclampsia and placental trisomy 16 mosaicism. Prenat Diagn 2006;26:956–961.
- Langlois S, Yong PJ, Yong SL, et al. Postnatal follow-up of prenatally diagnosed trisomy 16 mosaicism. Prenat Diagn 2006;26:548–558.
- Hsu WT, Shchepin DA, Mao R, et al. Mosaic trisomy 16 ascertained through amniocentesis: evaluation of 11 new cases. Am J Med Genet 1998;80:473–480.
- Groli C, Cerri V, Tarantini M, et al. Maternal serum screening and trisomy 16 confined to the placenta. Prenat Diagn 1996;16:685–689.
- Astner A, Schwinger E, Caliebe A, et al. Sonographically detected fetal and placental abnormalities associated with trisomy 16 confined to the placenta: A case report and review of the literature. Prenat Diagn 1998;18:1308–1315.
- Spencer K, Pertile MD, Bonacquisto L, et al. First trimester detection of trisomy 16 using combined biochemical and ultrasound screening. Prenat Diagn 2014;34:291–295.
- Verwoerd-Dikkeboom CM, van Heesch PN, Koning AH, et al. Embryonic delay in growth and development related to confined placental trisomy 16 mosaicism, diagnosed by I-Space Virtual Reality. Fertil Steril 2008;90:2017.e19–e22.
- Hadlock FP, Shah YP, Kanon DJ, Lindsey JV. Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US. Radiology 1992;182:501–505.
- Petracchi F, Igarzabal L, Crespo ML, Gadow E. Trisomy 16 detected by first trimester screening. Prenat Diagn 2009;29:1175–1176.
- Nicolaides KH, Heath V, Cicero S. Increased fetal nuchal translucency at 11-14 weeks. Prenat Diagn 2002;22:308–315.
- Sifakis S, Staboulidou I, Maiz N, et al. Outcome of pregnancies with trisomy 2 cells in chorionic villi. Prenat Diagn 2010;30:329–332.
- Baumann C, Delagarde R, Vuillard E, Oury JF. [Long-term follow-up of children with increased nuchal translucency and normal karyotype]. J Gynecol Obstet Biol Reprod (Paris) 2005;34:S97–S102.
- Comstock CH, Malone FD, Ball RH, et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol 2006;195:843–847.
- Creasy RK, Resnik R, Iams JDet al., Creasy and Resnik's Maternal-Fetal Medicine Expert Consult Premium Edition - Enhanced Online Features. London: Elsevier Health Sciences; 2013. p. 460.